文献速递腹部技术与安全CT

双能CT鉴别胰腺腺癌患者低密度肝脏病变

Dual-energy CT for differentiation of hypodense liver lesions in pancreatic adenocarcinoma.
PubMed 文献 · Eur Radiol · 2024-12-19

本回顾性研究纳入36例经活检证实胰腺腺癌且肝脏不确定病变经活检的患者,评估DECT光谱HU曲线鉴别低密度肝脏病变良恶性的准确性。共评估92个肝脏病变,光谱曲线斜率、碘浓度和虚拟强化诊断良恶性的AUC分别为0.948、0.946和0.937。光谱HU曲线和碘浓度对边界清晰低密度肝脏病变良恶性诊断具有高准确性。

要点

  • 光谱HU曲线斜率、碘浓度和虚拟强化诊断肝脏病变良恶性的AUC均较高(0.948、0.946、0.937)。
  • 最佳截断值:光谱曲线斜率1.36、碘浓度6.47(100 µg/cm3)、强化10.25。
  • DECT多能量信息可能有助于鉴别肝脏病变良恶性,减少额外检查需求。

核心结论

  • 边界清晰低密度肝脏病变的光谱HU曲线和碘浓度对良恶性诊断具有高准确性。

研究设计与样本

  • 回顾性、符合HIPAA的研究(2016年1月至2023年5月),纳入36例经活检证实胰腺腺癌且肝脏不确定病变经活检的患者,行腹部DECT扫描,以活检为参考标准评估92个肝脏病变。

关键影像表现/征象

  • 对每个低密度肝脏病变提供光谱HU曲线并计算斜率。
  • 记录病变Hounsfield单位、碘浓度和虚拟强化。

诊断标准与关键数值

  • 光谱曲线斜率最佳截断值1.36,诊断良恶性的AUC为0.948。
  • 碘浓度最佳截断值6.47(100 µg/cm3),诊断良恶性的AUC为0.946。
  • 虚拟强化最佳截断值10.25,诊断良恶性的AUC为0.937。

临床应用与阅片要点

  • 多能量CT的额外信息可能有助于鉴别低密度肝脏病变的良恶性,从而减少对昂贵额外评估的需求。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the accuracy of CT spectral HU curve assessment of hypodense liver lesions.

METHODS: In this retrospective HIPAA-compliant study (January 2016 through May 2023), patients with biopsy-proven pancreatic adenocarcinoma and a biopsied indeterminate liver lesion underwent a DECT abdominal CT scan. Spectral HU curves were provided for each hypodense liver lesion, and slopes were calculated. Lesion Hounsfield units, iodine concentration and virtual enhancement were recorded. The Wilcoxon rank sum test was used to compare malignant and benign lesions. Optimal cutoff points were estimated using ROC curves and Youden's Index.

RESULTS: Thirty-six patients (19 men, 17 women) with a mean age of 63 years ± 9 (standard deviation), a mean height of 170.9 cm ± 9.5, a mean weight of 69.8 kg ± 14.5, and a body mass index of 23.9 kg/m2 ± 3.5. Reference standard assessment identified 92 liver lesions (50 metastases, 24 cysts, 13 abscesses, 3 regions of inflammation, 2 hemangiomas) with a mean size of 1.1 cm ± 0.5. The mean interval between the CT and liver lesion biopsy was 24 days. A diagnosis of benign versus malignant was determined based on optimal cutoffs: spectral curve slope of 1.36, iodine concentration of 6.47 (100 µg/cm3), and enhancement of 10.25. The receiver operating curves (ROC) for diagnosis using spectral curve slope, iodine concentration, and virtual enhancement resulted in an area under the curve (AUC) of 0.948, 0.946, and 0.937, respectively.

CONCLUSION: Spectral HU curves and iodine concentration of well-defined hypodense liver lesions are highly accurate in the diagnosis of benign versus malignant lesions.

KEY POINTS: Question Limited evidence exists for spectral imaging diagnosis of liver lesions-can DECT accurately differentiate between benign and metastatic hypodense liver lesions? Findings Ninety-two hypodense liver lesions evaluated using HU keV curve slope, iodine concentration, and virtual enhancement resulted in accurate benign versus metastatic differentiation. Clinical relevance Hypodense liver lesions are a challenging issue at staging, often requiring further imaging, follow-up, and/or biopsy. The additional information from multi-energy CT can be useful to differentiate between benign and malignant lesions, thereby reducing the need for costly additional evaluation.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Jensen CT, Wong VK, Likhari GS, et al. Dual-energy CT for differentiation of hypodense liver lesions in pancreatic adenocarcinoma. Eur Radiol. 2024. PMID: 39699673. doi:10.1007/s00330-024-11291-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。